Biogency B&E Australia - English - Department of Health (Therapeutic Goods Administration)

biogency b&e

biogency pty ltd - ascorbic acid, quantity: 150 mg; d-alpha-tocopheryl acid succinate, quantity: 82.61 mg; zinc citrate dihydrate, quantity: 12.46 mg (equivalent: zinc, qty 4 mg); copper gluconate, quantity: 7.14 mg (equivalent: copper, qty 1 mg); tagetes erecta, quantity: 25 mg (equivalent: tagetes erecta, qty 1 g; equivalent: zeaxanthin, qty 1 mg); vaccinium myrtillus, quantity: 20 mg (equivalent: vaccinium myrtillus, qty 2 g); lycium chinense, quantity: 160 mg (equivalent: lycium chinense, qty 8 g); chrysanthemum sinense, quantity: 60 mg (equivalent: chrysanthemum sinense, qty 3 g); ginkgo biloba, quantity: 90 mg (equivalent: ginkgo biloba, qty 4.5 g); soy phosphatidylserine-enriched soy lecithin powder, quantity: 2.86 mg (equivalent: soy phosphatidylserine, qty 2 mg) - tablet, film coated - excipient ingredients: hypromellose; maltodextrin; silicon dioxide; d-alpha-tocopherol; beta-tocopherol; gamma-tocopherol; delta-tocopherol; sunflower oil; ascorbyl palmitate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; croscarmellose sodium; crospovidone; colloidal anhydrous silica; magnesium stearate; carnauba wax; purified water; macrogol 3350; chlorophyllin-copper complex - antioxidant/reduce free radicals formed in the body ; maintain/support eye health ; maintain/support healthy eyesight/vision ; maintain/support general health and wellbeing ; enhance/improve/promote/increase cognitive performance ; maintain/support cognitive function/mental function ; enhance/improve/promote/increase memory/recall ; maintain/support memory/mental recall

Biogency Growth Code Australia - English - Department of Health (Therapeutic Goods Administration)

biogency growth code

biogency pty ltd - leucine, quantity: 50 mg; lysine hydrochloride, quantity: 108.75 mg (equivalent: lysine, qty 87 mg); colecalciferol, quantity: 20 microgram; cyanocobalamin, quantity: 5 microgram; magnesium citrate, quantity: 647.25 mg (equivalent: magnesium, qty 100 mg); menaquinone 7, quantity: 45 microgram; nicotinamide, quantity: 10 mg; nicotinic acid, quantity: 20 mg; folic acid, quantity: 150 microgram; thiamine nitrate, quantity: 617 microgram (equivalent: thiamine, qty 500 microgram); riboflavin, quantity: 500 microgram; ferrous fumarate, quantity: 9.13 mg (equivalent: iron, qty 3 mg); zinc gluconate, quantity: 39.37 mg (equivalent: zinc, qty 5 mg); selenomethionine, quantity: 50 microgram (equivalent: selenium, qty 20 microgram) - tablet, chewable - excipient ingredients: povidone; acacia; sucrose; medium chain triglycerides; maize starch; dl-alpha-tocopherol; mannitol; maltodextrin; hypromellose; calcium hydrogen phosphate; calcium carbonate; glucose monohydrate; whole dry milk; chocolate brown ht; magnesium stearate; thaumatin; microcrystalline cellulose; flavour - maintain/support general health and wellbeing ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; helps enhance/promote bone mass/density ; maintain/support bone mass/density/integrity ; maintain/support bone strength ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life

Biogency B-Complex Chewable Australia - English - Department of Health (Therapeutic Goods Administration)

biogency b-complex chewable

biogency pty ltd - ascorbic acid, quantity: 100 mg; biotin, quantity: 200 microgram; cyanocobalamin, quantity: 2 microgram; riboflavine, quantity: 200 microgram; thiamine hydrochloride, quantity: 500 microgram; calcium pantothenate, quantity: 2.18 mg (equivalent: pantothenic acid, qty 2 mg); pyridoxine hydrochloride, quantity: 120 microgram (equivalent: pyridoxine, qty 100 microgram); levomefolate calcium, quantity: 542 microgram (equivalent: levomefolic acid, qty 500 microgram); sodium ascorbate, quantity: 113.122 mg (equivalent: ascorbic acid, qty 101.582 mg); terminalia ferdinandiana, quantity: 5 mg (equivalent: terminalia ferdinandiana, qty 50 mg) - tablet, chewable - excipient ingredients: colloidal anhydrous silica; magnesium stearate; isomalt; camellia sinensis; sunset yellow fcf; stevia rebaudiana; povidone; maize starch; maltodextrin; calcium hydrogen phosphate; hypromellose; flavour - maintain/support general health and wellbeing ; maintain/support (state vitamin/mineral/nutrient) levels in the body

Biogency Vitamin C Chewable Tablets Australia - English - Department of Health (Therapeutic Goods Administration)

biogency vitamin c chewable tablets

biogency pty ltd - sodium ascorbate, quantity: 281.2 mg (equivalent: ascorbic acid, qty 250 mg); ascorbic acid, quantity: 250 mg - tablet, chewable - excipient ingredients: colloidal anhydrous silica; sunset yellow fcf aluminium lake; maize starch; hypromellose; sorbitol; magnesium stearate; thaumatin; flavour - antioxidant/reduce free radicals formed in the body ; maintain/support collagen formation ; maintain/support general health and wellbeing ; maintain/support gum health ; maintain/support healthy immune system function ; helps enhance/promote/increase absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support (state vitamin/mineral) within normal range ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; maintain/support wound healing

Biogency Synext Australia - English - Department of Health (Therapeutic Goods Administration)

biogency synext

biogency pty ltd - pyridoxine hydrochloride, quantity: 610 microgram (equivalent: pyridoxine, qty 500 microgram); nicotinic acid, quantity: 100 mg; zinc glycinate, quantity: 23.33 mg (equivalent: zinc, qty 7 mg); leucine, quantity: 100 mg; riboflavin, quantity: 1 mg; reynoutria japonica, quantity: 60 mg (equivalent: reynoutria japonica, qty 6 g); levomefolate calcium, quantity: 162 microgram (equivalent: levomefolic acid, qty 150 microgram); ubidecarenone, quantity: 50 mg; heavy magnesium oxide, quantity: 50 mg (equivalent: magnesium, qty 30 mg); piper nigrum, quantity: 6 mg (equivalent: piper nigrum, qty 300 mg); biotin, quantity: 1 mg; selenomethionine, quantity: 75 microgram (equivalent: selenium, qty 30 microgram); chromium picolinate, quantity: 64.4 microgram (equivalent: chromium, qty 8 microgram); quercetin, quantity: 200 mg; curcuma longa, quantity: 200 mg (equivalent: curcuma longa, qty 4 g); punica granatum, quantity: 200 mg (equivalent: punica granatum, qty 18 g); cyanocobalamin, quantity: 10 microgram - tablet, film coated - excipient ingredients: carnauba wax; croscarmellose sodium; microcrystalline cellulose; maltodextrin; povidone; calcium hydrogen phosphate dihydrate; pregelatinised starch; crospovidone; silicon dioxide; purified water; hypromellose; magnesium stearate; calcium hydrogen phosphate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin; glyceryl mono and dicaprylocaprate; sodium lauryl sulfate - maintain/support energy production ; anti-inflammatory/relieve inflammation ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; maintain/support blood capillary health ; maintain/support (state vitamin/mineral/nutrient) levels in the body

Vman Pack Australia - English - Department of Health (Therapeutic Goods Administration)

vman pack

biogency pty ltd - excipient ingredients: - ? maintain/support energy production ? helps enhance/promote healthy blood circulation ? maintain/support (state vitamin/mineral/nutrient) levels in the body ? maintain/support healthy sexual function ? traditionally used in chinese medicine to male tonic

Synext Tablets Australia - English - Department of Health (Therapeutic Goods Administration)

synext tablets

biogency pty ltd - biotin,cyanocobalamin,curcuma longa,heavy magnesium oxide,leucine,nicotinamide,nicotinic acid,pyridoxine hydrochloride,piper nigrum,quercetin,riboflavin,reynoutria japonica,ubidecarenone -